SCHEMBL526121

SCHEMBL526121

CC(CCCCCF)(C(=O)O)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.41
CPT2 P23786 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ACLY P53396 1/20 0.41
ACACB O00763 1/20 0.39
ACACA Q13085 1/20 0.39
ODC1 P11926 2/20 0.36
ARG1 P05089 1/20 0.34
ARG2 P78540 1/20 0.34
CES2 O00748 1/20 0.32
TSHR P16473 2/20 0.32
ALDH1A1 P00352 1/20 0.32
CYP2D6 P10635 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31
TBXAS1 P24557 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29496308 1.00 FFAR1 (0.41) FFAR1CPT2TDP1ACLYACACB
SCHEMBL527050 0.98 FFAR1 (0.38) FFAR1CPT2TDP1ACLYACACB
SCHEMBL3192678 0.91 ODC1 (0.39) FFAR1CPT2TDP1ACLYACACB
SCHEMBL1009937 0.85 FFAR1 (0.34) FFAR1CPT2TDP1ACLYACACB
SCHEMBL5474459 0.80 ALDH1A1 (0.42) FFAR1CPT2TDP1ACLYACACB
SCHEMBL25045699 0.79 ACLY (0.57) FFAR1CPT2TDP1ACLYACACB
SCHEMBL337569 0.79 GGPS1 (0.50) FFAR1TDP1CES2TSHRALDH1A1
SCHEMBL9153322 0.79 GGPS1 (0.50) FFAR1TDP1CES2TSHRALDH1A1
SCHEMBL10339977 0.79 GGPS1 (0.50) FFAR1TDP1CES2TSHRALDH1A1
SCHEMBL5859353 0.79 GGPS1 (0.50) FFAR1TDP1CES2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 903 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122084715-A Electrochemical luminescence immunosensor with low trigger potential and preparation method and application thereof 2026-05-26 CN claimed
CN-121534164-B Functional composition, conditioner and use for treating or preventing bone and joint diseases 北京青颜博识健康管理有限公司 2026-05-15 CN claimed
US-20260021190-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A PENTA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES MERCK SHARP & DOHME LLC (US) 2026-01-22 US claimed
US-12427187-B2 Glucose-responsive insulin conjugates MERCK SHARP & DOHME LLC (US) 2025-09-30 US claimed
EP-4615487-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A PENTA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES Merck Sharp & Dohme LLC (US) 2025-09-17 EP claimed
US-20250269070-A1 Fluorescent Marker UCL BUSINESS PLC (GB) 2025-08-28 US claimed
CN-120192856-A Edible and medicinal red yeast rice with high esterifying enzyme activity and application thereof 沈阳农业大学 2025-06-24 CN claimed
CN-119950669-B Pharmaceutical composition for treating peptic gastric ulcer and preparation method thereof 中国人民解放军南部战区总医院 2025-06-03 CN claimed
CN-120077271-A Absorbent article having test paper for white tape and test paper for white tape used in absorbent article 尤妮佳股份有限公司 2025-05-30 CN claimed
CN-119950669-A Pharmaceutical composition for treating peptic gastric ulcer and preparation method thereof 中国人民解放军南部战区总医院 2025-05-09 CN claimed
CN-111286489-B Tumor angiogenesis model and preparation method and application thereof 皖南医学院第一附属医院(皖南医学院弋矶山医院) 2022-04-15 CN claimed
EP-3980052-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES MERCK SHARP & DOHME CORP. (US) 2022-04-13 EP claimed
CN-114295821-A Indoor quality assessment sample of thrombus elastogram experimental reagent and preparation method and application thereof 深圳麦科田生物医疗技术股份有限公司 2022-04-08 CN claimed
CN-110804639-B Method for promoting esterification of microalgae astaxanthin 中国科学院天津工业生物技术研究所 2022-04-08 CN claimed
CN-114271411-A Penaeus vannamei fermented feed capable of improving intestinal tracts and increasing survival rate 山东博华高效生态农业科技有限公司 2022-04-05 CN claimed
US-20220096867-A1 SYSTEMS AND METHODS FOR USE IN EMISSION GUIDED RADIATION THERAPY OXFORD FINANCE LLC 2022-03-31 US claimed
CN-114191531-A Artemisia argyi fermentation product for cattle and sheep diarrhea and preparation method thereof 四川辉氏生物技术有限公司 2022-03-18 CN claimed
CN-114152696-A Non-target screening method for multiple PPCPs in cattle muscle 大连海关技术中心 2022-03-08 CN claimed
CN-114113388-A Method for detecting related substances in 4-oximinomethyl-1-naphthoic acid 丽珠集团新北江制药股份有限公司 2022-03-01 CN claimed
CN-114062535-A Method for detecting content of volatile and semi-volatile unknown substances in medical instrument leaching liquor 苏州药明康德新药开发有限公司 2022-02-18 CN claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12427187-B2 Glucose-responsive insulin conjugates GPR119, IRS1, INSR FFAR1 272/4885CPT2 3954/4885TDP1 4020/4885
US-20260021190-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES COMPRISING A PENTA-VALENT SUGAR CLUSTER FOR TREATMENT OF DIABETES INSR, GPR119, GLP1R FFAR1 44/4885CPT2 1212/4885TDP1 4160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.